Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of ARRY-371797 (PF-07265803) in LMNA-Related Dilated Cardiomyopathy
2017-004310-25Phase 3Unknown
- Sponsor
- Array BioPharma
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in dilated cardiomyopathy (DCM) comparing ARRY-371797 with Placebo (2 arms). Status: unknown.
02
Drugs
emprumapimod
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on 2017-004310-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004310-25.